Generic Name and Formulations:
Iron (as carbonyl) 100mg, Vit. C 250mg; tabs.
Indications for ICAR-C:
Iron deficiency and iron deficiency anemia.
1 tab once daily.
Use Ped Susp. 15mg (of iron) once daily.
Folic acid may mask pernicious anemia. Monitor hemoglobin, hematocrit, reticulocyte count periodically. Elderly.
Inhibits tetracycline absorption. Aluminum- or magnesium-containing antacids inhibit iron absorption.
Nausea, abdominal discomfort and pain, constipation, diarrhea, masks occult bleeding, black stools.
Ped Susp—4oz (w. dosing syringe)
Sign Up for Free e-newsletters
- Real World Results May Not Mirror Clinical Study Outcomes in Multiple Myeloma
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Handling Chemotherapy Premedications
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
- Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer
- Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|